A detailed history of Monarch Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Monarch Capital Management Inc holds 53,330 shares of ABBV stock, worth $8.85 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares
53,330
Previous 54,264 1.72%
Holding current value
$8.85 Million
Previous $8.41 Million 15.48%
% of portfolio
2.79%
Previous 2.58%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $149,271 - $170,081
-934 Reduced 1.72%
53,330 $9.71 Million
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $163,056 - $183,639
-1,185 Reduced 2.14%
54,264 $8.41 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $44,084 - $51,034
-330 Reduced 0.59%
55,449 $8.27 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $69,965 - $87,067
-528 Reduced 0.94%
55,779 $7.52 Million
Q1 2023

Apr 25, 2023

SELL
$144.61 - $166.54 $165,578 - $190,688
-1,145 Reduced 1.99%
56,307 $8.97 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $366,936 - $440,053
-2,653 Reduced 4.41%
57,452 $0
Q3 2022

Oct 20, 2022

SELL
$134.21 - $153.93 $294,993 - $338,338
-2,198 Reduced 3.53%
60,105 $8.07 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $85,737 - $109,000
-623 Reduced 0.99%
62,303 $9.54 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $298,538 - $370,402
-2,262 Reduced 3.47%
62,926 $10.2 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $99,157 - $125,463
-923 Reduced 1.4%
65,188 $8.83 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $231,420 - $262,696
2,175 Added 3.4%
66,111 $7.13 Million
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $98,476 - $109,708
936 Added 1.49%
63,936 $7.2 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $47,058 - $51,805
460 Added 0.74%
63,000 $6.82 Million
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $127,737 - $172,459
-1,587 Reduced 2.47%
62,540 $6.7 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $8,333 - $9,780
97 Added 0.15%
64,127 $5.62 Million
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $64,345 - $86,103
877 Added 1.39%
64,030 $6.29 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $71,272 - $108,057
1,105 Added 1.78%
63,153 $4.81 Million
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $1,803 - $2,256
-25 Reduced 0.04%
62,048 $5.49 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $148,884 - $179,002
2,364 Added 3.96%
62,073 $4.7 Million
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $121,873 - $155,782
1,855 Added 3.21%
59,709 $4.34 Million
Q1 2019

May 01, 2019

BUY
$77.14 - $90.79 $95,653 - $112,579
1,240 Added 2.19%
57,854 $4.66 Million
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $83,299 - $102,730
1,070 Added 1.93%
56,614 $5.22 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $61,347 - $68,199
-690 Reduced 1.23%
55,544 $5.25 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $243,842 - $288,520
-2,716 Reduced 4.61%
56,234 $5.21 Million
Q1 2018

Apr 18, 2018

SELL
$92.01 - $123.21 $244,470 - $327,368
-2,657 Reduced 4.31%
58,950 $5.58 Million
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $729,287 - $799,724
-8,143 Reduced 11.67%
61,607 $5.96 Million
Q3 2017

Oct 18, 2017

BUY
$69.85 - $89.22 $4.87 Million - $6.22 Million
69,750
69,750 $6.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Monarch Capital Management Inc Portfolio

Follow Monarch Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.